
Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-5000
Dr. Stockton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shannon Stockton is an Oncology specialist based in Nashville, TN with subspecialties in Gastrointestinal Cancer and Hematologic Oncology. She completed her medical education at the University of Florida College of Medicine in 2015, before finishing her residency in Internal Medicine at Vanderbilt University Medical Center in 2021. Dr. Stockton has several publications in notable journals including Blood Cancer Journal, The Oncologist, Blood Advances, and British Journal of Haematology, and her work has been cited by other publications multiple times.
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2018 - 2021
- University of Florida College of MedicineClass of 2015
Certifications & Licensure
- TN State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- ABIMHematology
- ABIMInternal Medicine
Publications & Presentations
PubMed
- 3 citationsClonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository.Morgan L Shannon, J Brett Heimlich, Sydney Olson, Ariana Debevec, Zachary Copeland
Blood Advances. 2024-07-09 - Evolving or immutable - phase I solid tumor trials in the era of precision oncology.Shannon S Stockton, G Dan Ayers, Cody Lee, Heather Laferriere, Satya Das
Investigational New Drugs. 2024-06-01 - 1 citationsEvolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision Oncology.Shannon S Stockton, G Dan Ayers, Cody Lee, Heather Laferriere, Satya Das
Research Square. 2024-04-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: